BICO Group AB Class B
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Anders Fogelberg
- Full Time Employees
- 554
- Sector
- Health technology
- Industry
- Biotechnology
- Address
- Grafiska vägen 2B Gothenburg VG Sweden 412 63
- IPO Date
- Nov 3, 2016
- Website
- bico.com
- Similar Companies
- Business
- BICO Group AB (publ) (STO: BICO) develops, manufactures and commercializes lab automation software, hardware and integrated solutions for life science research, diagnostics manufacturing and biopharmaceutical applications; its core offerings span three primary segments including Bioprinting with 3D bioprinters, bioinks and related services from brands such as CELLINK for tissue engineering, 3D in vitro models and drug discovery; Life Science Solutions encompassing advanced instrumentation and consumables for cell culture, imaging, sorting, sample preparation, single-cell and spheroid dispensing, liquid handling such as the I.DOT series from SCIENION and DISPENDIX, hybrid microscopes from NANO-CELLECT, mixing solutions from Flownova, and extracellular matrix proteins from Advanced BioMatrix; and Lab Automation featuring the proprietary hardware-agnostic Green Button Go Suite software alongside automation integration, engineering and consulting services from Biosero to enable connected workflows and end-to-end laboratory systems. Incorporated in 2016 and headquartered in Gothenburg, Sweden, the company operates globally across North America, Europe and Asia with sales organizations and distributor networks serving pharmaceutical, biopharmaceutical, biotechnology, diagnostics, academia, research and cosmetics sectors; it maintains over 48,000 instruments in the field across more than 25 countries and boasts citations in over 12,000 publications. Formerly known as Cellink AB (publ), BICO rebranded in August 2021; recent developments include the divestiture of MatTek Corp. and Visikol Inc. to Sartorius for net proceeds of USD 77.2 million completed in July 2025 following regulatory approval to streamline focus on lab automation and high-margin workflows, repurchase of convertible bonds totaling SEK 276 million nominal in February 2025 and an additional SEK 98 million in August 2025 to optimize capital structure, launch of the I.DOT LT non-contact liquid handler by DISPENDIX in May 2025 for precise nano-to-microliter dispensing in NGS, PCR and assays, a Biosero contract for integrated lab automation solutions valued at USD 15.2 million announced in September 2025, strategic leadership and process enhancements at Biosero including new management and gate-stage project models to address capacity constraints amid high demand, and an updated BICO 2.0 strategy unveiled at the Capital Markets Day in September 2024 emphasizing commercial excellence, operational synergies and sustainable growth through end-to-end automation, AI integration and recurring revenue expansion.
Company News
BICO Group AB (publ) (BCCOY) Q2 2026 Earnings Call Transcript
BICO Group AB (publ) (BCCOY) Q1 2026 Earnings Call Transcript
BICO Group AB (publ) (BCCOY) Q4 2025 Earnings Call Transcript
BICO Group AB (publ) (OTCMKTS:CLLKF) Short Interest Update
BICO Group AB (publ) (OTCMKTS:CLLKF) Sees Significant Growth in Short Interest
BICO Group AB (publ) (OTCMKTS:CLLKF) Trading Down 8.1% – Should You Sell?
BICO Group AB (publ) (BCCOY) Q3 2025 Earnings Call Transcript
BICO Group AB (publ) (CLLKF) Q2 2025 Earnings Call Transcript
BICO Group AB (publ) (CLLKF) Q1 2025 Earnings Call Transcript
BICO Group AB (CLLKF) Q4 2024 Earnings Call Transcript
BICO Group AB (CLLKF) Q3 2024 Earnings Call Transcript
BICO Group AB (publ) (CLLKF) Q2 2024 Earnings Call Transcript
The 3 Best 3D Bioprinting Stocks to Buy Now
Lab Instrument Industry Update - New Commercial Entrants
BICO Group AB (publ) (CLLKF) Q1 2024 Earnings Call Transcript
3 3D Printing Stocks With the Potential to Make You an Overnight Millionaire
BICO Group AB (publ) (CLLKF) Q4 2023 Earnings Call Transcript
BICO: Too Many Unknowns
BICO Group AB (publ) (CLLKF) Q2 2023 Earnings Call Transcript
BICO Group AB (publ) (CLLKF) Q1 2023 Earnings Call Transcript